Nagaileben Co Ltd
TSE:7447

Watchlist Manager
Nagaileben Co Ltd Logo
Nagaileben Co Ltd
TSE:7447
Watchlist
Price: 2 134 JPY -0.97% Market Closed
Market Cap: 67.2B JPY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Nagaileben Co Ltd stock under the Base Case scenario is 1 409.41 JPY. Compared to the current market price of 2 134 JPY, Nagaileben Co Ltd is Overvalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 409.41 JPY
Overvaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.9
P/S
P/S
Price to Sales
3.9
vs History
68
vs Industry
32
Median 3Y
4
Median 5Y
4.3
Industry
2.2
Forward
3.7
More Details
24
P/E
P/E
Price to Earnings
24
vs History
23
vs Industry
26
Median 3Y
21.5
Median 5Y
22.2
Industry
21.8
Forward
22.3
More Details
30.9
P/OCF
P/OCF
Price to OCF
30.9
vs History
15
vs Industry
13
Median 3Y
28.4
Median 5Y
22.9
Industry
13.4
More Details
35
P/FCFE
P/FCFE
Price to FCFE
35
vs History
12
vs Industry
16
Median 3Y
30.8
Median 5Y
24.1
Industry
19
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
66
vs Industry
51
Median 3Y
1.6
Median 5Y
1.8
Industry
2.1
More Details
2.6
EV/S
EV/S
Enterprise Value to Sales
2.6
vs History
60
vs Industry
44
Median 3Y
2.5
Median 5Y
2.8
Industry
2.3
Forward
2.4
More Details
6.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.2
vs History
50
vs Industry
41
Median 3Y
5.5
Median 5Y
6.4
Industry
4.8
More Details
10.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.3
vs History
31
vs Industry
35
Median 3Y
8.9
Median 5Y
9.7
Industry
11.4
Forward
9.9
More Details
11
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11
vs History
30
vs Industry
39
Median 3Y
9.4
Median 5Y
10.3
Industry
15.5
More Details
20.1
EV/OCF
EV/OCF
Enterprise Value to OCF
20.1
vs History
15
vs Industry
24
Median 3Y
17.9
Median 5Y
15.8
Industry
13.3
More Details
22.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.8
vs History
15
vs Industry
25
Median 3Y
19.7
Median 5Y
16.6
Industry
17.1
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
76
vs Industry
38
Median 3Y
2.3
Median 5Y
2.7
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Nagaileben Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Nagaileben Co Ltd
TSE:7447
66.1B JPY 3.9 24 10.3 11
CH
Alcon AG
SIX:ALC
38.8B CHF 4.7 46.1 19.4 37
JP
Hoya Corp
TSE:7741
5.7T JPY 6.8 27.6 18.2 21.8
DK
Coloplast A/S
CSE:COLO B
163.4B DKK 6 33.5 20.7 24.4
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 3.4 32.1 15.3 18.6
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 36.8 208.6 341.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
7B USD 4.5 22.3 12.9 14.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.3B CNY 9.3 22.3 19.2 19.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.1 46.2 21.2 36
CH
Ypsomed Holding AG
SIX:YPSN
4.7B CHF 7.6 62.7 30.3 56.8
KR
HLB Inc
KOSDAQ:028300
7.2T KRW 106.3 -78.7 -63.9 -60.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Nagaileben Co Ltd
TSE:7447
Average EV/EBITDA: 37.6
10.3
5%
2.1
CH
Alcon AG
SIX:ALC
19.4
11%
1.8
JP
Hoya Corp
TSE:7741
18.2
14%
1.3
DK
Coloplast A/S
CSE:COLO B
20.7
11%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.3
16%
1
UK
ConvaTec Group PLC
LSE:CTEC
208.6
10%
20.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
12.9
23%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
19.2
26%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
21.2
14%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
30.3
31%
1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -63.9 N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.